Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Gallagher

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Urologia Internationalis|January 1, 1995
Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in manR T Oliver, J V Joseph, C J Gallagher
Journal of Clinical Anesthesia|March 1, 1991
Secondary polycythemia does not increase the risk of perioperative hemorrhagic or thrombotic complicationsD A Lubarsky, C J Gallagher, J L Berend
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Accelerated cisplatin-based chemotherapy for advanced bladder cancerC Boshoff, R T Oliver, C J Gallagher, et al.
Biochemical Society Transactions|August 1, 1996
Elucidating the role of gonadotrophins in endometrial cancer cell growthC M Bax, E Chatzaki, S Davies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancerC J Gallagher, E Wiltshaw, R E Coleman, et al.
British Journal of Cancer|January 26, 2008
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancerM Bhattacharyya, D Ryan, R Carpenter, et al.
Vox Sanguinis|April 26, 2007
Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapyR C J Gallagher, M Waterfall, K Samuel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histologyC J Gallagher, A Copplestone, J D Meikle, et al.
Vox Sanguinis|January 12, 2010
Analysis of Wnt pathway genes during ex vivo expansion and neutrophil differentiation of umbilical-cord-blood-derived CD34 cellsR C J Gallagher, O Tura-Ceide, M Turner, et al.
Vox Sanguinis|January 28, 2014
Use of IL3 and chromatin-modifying reagents valproic acid and 5-aza-2'-deoxycytidine to affect mobilized peripheral blood CD34+ cell fate decisionsJ Liu, K Samuel, M L Turner, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Urologia Internationalis|January 1, 1995
Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in manR T Oliver, J V Joseph, C J Gallagher
Journal of Clinical Anesthesia|March 1, 1991
Secondary polycythemia does not increase the risk of perioperative hemorrhagic or thrombotic complicationsD A Lubarsky, C J Gallagher, J L Berend
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Accelerated cisplatin-based chemotherapy for advanced bladder cancerC Boshoff, R T Oliver, C J Gallagher, et al.
Biochemical Society Transactions|August 1, 1996
Elucidating the role of gonadotrophins in endometrial cancer cell growthC M Bax, E Chatzaki, S Davies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancerC J Gallagher, E Wiltshaw, R E Coleman, et al.
British Journal of Cancer|January 26, 2008
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancerM Bhattacharyya, D Ryan, R Carpenter, et al.
Vox Sanguinis|April 26, 2007
Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapyR C J Gallagher, M Waterfall, K Samuel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histologyC J Gallagher, A Copplestone, J D Meikle, et al.
Vox Sanguinis|January 12, 2010
Analysis of Wnt pathway genes during ex vivo expansion and neutrophil differentiation of umbilical-cord-blood-derived CD34 cellsR C J Gallagher, O Tura-Ceide, M Turner, et al.
Vox Sanguinis|January 28, 2014
Use of IL3 and chromatin-modifying reagents valproic acid and 5-aza-2'-deoxycytidine to affect mobilized peripheral blood CD34+ cell fate decisionsJ Liu, K Samuel, M L Turner, et al.
Pageof 6